Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies during COVID-19 Pandemic: A Single-Arm, Before-and-After Study

Author(s)

Murteira R1, Romano S2, Teixeira I2, Galante H2, Sousa S2, Teixeira Rodrigues A2
1Centre for Health Evaluation & Research, National Association of Pharmacies (CEFAR-IS/ANF), Lisboa, 11, Portugal, 2Centre for Health Evaluation & Research, National Association of Pharmacies (CEFAR-IS/ANF), Lisboa, Portugal

OBJECTIVES: Ensuring the continuing of care is an imperative need, therefore throughout COVID-19 outbreak, the Portuguese Government released directives to guarantee hospital-only medicines' dispensing through the community pharmacy, reducing contacts between patients and Hospitals. This study aims to measure the value generated by the intervention of the community pharmacy in the dispensing of hospital medicines.

METHODS: A single-arm, before-and-after study with 3-month follow-up, was carried out in Portugal, enrolling a randomly selected sample of patients with at least one dispensation of a hospital-only medicine through the community pharmacy. Data was collected through a structured questionnaire applied by telephone interview from May 15th to October 10th, 2020. Main outcomes were access to medicines, therapeutic adherence (MAT-7), health-related quality-of-life (EQ-5D-3L), satisfaction with the service, travel and waiting time, and related costs to patients.

RESULTS: A total of 603 patients/caregivers accepted to participate in the study. The mean age was 55 years old (SD=16) and 50.6% were male. On average, the estimated time gained with the community pharmacy service was 115.1 minutes/visit compared to hospital. Annual savings derived from travel expenses (€237.6) and absenteeism (€67.4) reduction account for 271.6€/patient. There was an increase in the mean score of adherence to therapy (p<0.05) and no statistically significant changes in the mean EQ-5D-3L score. Overall, 91% of respondents would choose to continue to have access to their medication at the community pharmacy, in post-pandemic scenario. Participants reported an increase of satisfaction levels in all evaluated domains – pharmacist’s availability, opening hours, waiting time, privacy conditions and overall experience.

CONCLUSIONS: Changing the dispense setting to the community pharmacies seems to promote better access, health outcomes and satisfaction for patients. Moreover, it ensures the persistence of treatments, promotes savings for patients and society, and reduces the burden of health care services, representing a crucial public health measure.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSA247

Topic

Epidemiology & Public Health, Health Service Delivery & Process of Care, Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance, Patient-reported Outcomes & Quality of Life Outcomes, Pharmacist Interventions and Practices, Public Health

Disease

Infectious Disease (non-vaccine), Multiple Diseases, Neurological Disorders, Oncology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×